Website beoordeling nlc.health
NLC Health Ventures | We find, build and scale health innovations
Gegenereerd op Februari 14 2026 18:49 PM
Oude statistieken? UPDATE !
De score is 62/100
SEO Content
Title
NLC Health Ventures | We find, build and scale health innovations
Lengte : 65
Perfect, uw title tag bevat tussen de 10 en 70 karakters.
Description
Discover NLC Health Ventures, a world-leading healthtech venture builder and investment fund. We transform patient lives by bringing science to life.
Lengte : 149
Perfect, uw meta description bevat tussen de 70 en 160 karakters.
Keywords
Erg slecht. We hebben geen meta keywords gevonden in uw website. Gebruik deze gratis online meta tags generator om keywords te genereren.
Og Meta Properties
Goed, uw page maakt gebruik van Og Properties.
| Property | Content |
|---|---|
| type | website |
Headings
| H1 | H2 | H3 | H4 | H5 | H6 |
| 1 | 5 | 44 | 0 | 0 | 0 |
- [H1] Access a portfolio of 50+ healthcare companies
- [H2] We are NLC Health Ventures — a world-leading healthtech venture builder and early-stage investor. Our purpose is to bring science to life by bridging the gap between scientific discoveries and market-ready solutions that transform patients’ lives.
- [H2] Our expertise
- [H2] Our impact
- [H2] Insights
- [H2] Join us in creating a healthier future
- [H3] Cardiovascular & IGT
- [H3] Orthopedics & Spine
- [H3] Therapeutics
- [H3] New Markets
- [H3] Ansana Secures a EUR 1.5 Million Seed Round to Bring Smart Sterilization Technology to Market
- [H3] Ansana Secures a EUR 1.5 Million Seed Round to Bring Smart Sterilization Technology to Market
- [H3] Venture Update: Venous Stent appoints Darren Spencer as CEO and participates at LSI Europe
- [H3] Venture Update: Venous Stent appoints Darren Spencer as CEO and participates at LSI Europe
- [H3] NLC Health Impact Fund backs medtech innovation Amotio to transform revision joint surgeries with a GBP 210,000 investment
- [H3] NLC Health Impact Fund backs medtech innovation Amotio to transform revision joint surgeries with a GBP 210,000 investment
- [H3] Genorare Secures Pre-Seed Funding to Revolutionize Rare Disease Diagnosis with AI
- [H3] Genorare Secures Pre-Seed Funding to Revolutionize Rare Disease Diagnosis with AI
- [H3] NLC Health Ventures introduces new venture transforming cardiovascular care
- [H3] NLC Health Ventures introduces new venture transforming cardiovascular care
- [H3] NLC Health Ventures launches new venture revolutionizing Rheumatoid Arthritis care
- [H3] NLC Health Ventures launches new venture revolutionizing Rheumatoid Arthritis care
- [H3] NeurOdys Therapeutics Secures Pre-Seed Funding to Advance Small Molecule Therapies for Neurodegenerative Diseases
- [H3] NeurOdys Therapeutics Secures Pre-Seed Funding to Advance Small Molecule Therapies for Neurodegenerative Diseases
- [H3] From invention to impact: Inside NLC’s venture creation and selection process
- [H3] From invention to impact: Inside NLC’s venture creation and selection process
- [H3] Driving return and impact: Inside The NLC Health Impact Fund’s vision and strategy
- [H3] Driving return and impact: Inside The NLC Health Impact Fund’s vision and strategy
- [H3] The Future of Healthcare: A conversation with Dr. Fenna Heyning on reinventing hospitals for the digital age
- [H3] The Future of Healthcare: A conversation with Dr. Fenna Heyning on reinventing hospitals for the digital age
- [H3] Introducing DiaphOne Therapeutics: Developing small molecule antagonists
- [H3] Introducing DiaphOne Therapeutics: Developing small molecule antagonists
- [H3] Derisking early-stage investments to solve global healthcare challenges
- [H3] Derisking early-stage investments to solve global healthcare challenges
- [H3] Innovation and collaboration is the cure to solving the healthcare crisis
- [H3] Innovation and collaboration is the cure to solving the healthcare crisis
- [H3] The power of additionality: Why impact investing should focus on building companies that otherwise wouldn’t exist
- [H3] The power of additionality: Why impact investing should focus on building companies that otherwise wouldn’t exist
- [H3] NLC & HMG launch the Global Open Challenge!
- [H3] NLC & HMG launch the Global Open Challenge!
- [H3] NLC Health Ventures and HMG are announcing partnership to accelerate global health tech innovations
- [H3] NLC Health Ventures and HMG are announcing partnership to accelerate global health tech innovations
- [H3] Nina Rijnders: Impact investing for philanthropic fund (In Dutch)
- [H3] Nina Rijnders: Impact investing for philanthropic fund (In Dutch)
- [H3] SERDA Therapeutics Announces Completion of First Phase 1 Clinical Study of SN514
- [H3] SERDA Therapeutics Announces Completion of First Phase 1 Clinical Study of SN514
- [H3] Introducing Exolvo: NLC Health Ventures launches new early-stage drug delivery company
- [H3] Introducing Exolvo: NLC Health Ventures launches new early-stage drug delivery company
- [H3] Dutch health insurer VGZ invests in NLC Health Ventures
- [H3] Dutch health insurer VGZ invests in NLC Health Ventures
Afbeeldingen
We vonden 59 afbeeldingen in de pagina.
23 alt attributen ontbreken. Voeg alternatieve text toe zodat zoekmachines beter kunnen beoordelen wat het onderwerp van de afbeeldingen is.
Text/HTML Ratio
Ratio : 0%
De ratio van text tot HTML code is below 15 procent, dit betekent dat uw pagina waarschijnlijk meer tekst nodig heeft.
Flash
Perfect, geen Flash content gevonden in uw website.
Iframe
Jammer, u heeft Iframes in uw website, dit betekent dat deze content niet kan worden geïndexeerd.
SEO Links
Herschreven URL
Perfect. Uw links zien er vriendelijk uit!
Underscores in de URLs
Perfect! Geen underscores gevonden in uw URLs.
In-page links
We vonden een totaal van 27 links inclusie 4 link(s) naar bestanden
| Ankertekst | Type | samenstelling |
|---|---|---|
| Learn more | Intern | doFollow |
| cookie policy | Extern | doFollow |
| For Inventors | Intern | doFollow |
| For Investors | Intern | doFollow |
| For Corporates | Intern | doFollow |
| Portfolio | Intern | doFollow |
| About | Intern | doFollow |
| Investor login | Extern | doFollow |
| Investor login | Intern | doFollow |
| Find | Intern | doFollow |
| - | Intern | doFollow |
| - | Extern | doFollow |
| - | Extern | doFollow |
| Follow us on Linkedin | Extern | doFollow |
| Team | Intern | doFollow |
| Insights | Intern | doFollow |
| Careers | Intern | doFollow |
| Funds | Intern | doFollow |
| Ventures | Intern | doFollow |
| Cardiovascular & IGT | Intern | doFollow |
| Orthopedics & Spine | Intern | doFollow |
| Therapeutics | Intern | doFollow |
| New Markets | Intern | doFollow |
| - | Extern | doFollow |
| Terms & Conditions | Extern | doFollow |
| Privacy Statement | Extern | doFollow |
| Disclaimer | Extern | doFollow |
SEO Keywords
Keywords Cloud
nlc access health innovations healthcare companies scale portfolio ventures build
Keywords Consistentie
| Keyword | Content | Title | Keywords | Description | Headings |
|---|---|---|---|---|---|
| health | 3 |  |
 |
|
|
| nlc | 2 | |
|
|
|
| ventures | 1 | |
|
|
|
| build | 1 | |
|
|
|
| scale | 1 | |
|
|
|
Bruikbaarheid
Url
Domein : nlc.health
Lengte : 10
Favicon
Goed, uw website heeft een favicon.
Printbaarheid
Jammer. We vonden geen Print-Vriendelijke CSS.
Taal
Goed. Uw ingestelde taal is en.
Dublin Core
Deze pagina maakt geen gebruik van Dublin Core.
Document
Doctype
HTML 5
Encoding
Perfect. Uw ingestelde Charset is UTF-8.
W3C Validiteit
Fouten : 0
Waarschuwingen : 0
E-mail Privacy
Waarschuwing! Er is op zijn minst 1 e-mailadres gevonden als platte tekst. (voorkom spam!). Gebruik deze gratis antispam protector om e-mailadressen te verbergen voor spammers.
Niet ondersteunde HTML
Geweldig! We hebben geen niet meer ondersteunde HTMl tags gevonden in uw HTML.
Speed Tips
|
Geweldig, uw website heeft geen tabellen in een tabel. |
|
Jammer, uw website maakt gebruik van inline styles. |
|
Geweldig, uw website heeft een correct aantal CSS bestanden. |
|
Jammer, uw website heeft teveel JS bestanden (meer dan 6). |
|
Perfect, uw website haalt voordeel uit gzip. |
Mobile
Mobile Optimization
|
Apple Icon |
|
Meta Viewport Tag |
|
Flash content |
Optimalisatie
XML Sitemap
Geweldig, uw website heeft een XML sitemap.
| https://www.nlc.health/sitemap.xml |
Robots.txt
https://nlc.health/robots.txt
Geweldig uw website heeft een robots.txt bestand.
Analytics
Ontbrekend
We hadden niet op te sporen van een analytics tool op deze website geplaatst.
Web Analytics laat u toe de bezoekersactiviteit op uw website te meten. U zou minstens 1 Analytics tool geïnstalleerd moeten hebben en een extra tool voor de bevestiging van de resultaten.
PageSpeed Insights
Device
Categorieën
Free SEO Testing Tool
Website review is een gratis tool waarmee u eenvoudig uw website kunt analyseren